Cargando…
Protective Effect of Arbidol Against Pulmonary Fibrosis and Sepsis in Mice
From the perspective of epidemiology, viral immunology and current clinical research, pulmonary fibrosis may become one of the complications of patients with Coronavirus Disease 2019 (COVID-19). Cytokine storm is a major cause of new coronavirus death. The purpose of this study was to explore the ef...
Autores principales: | Li, Hailong, Liu, Rui, Zhang, Ruotong, Zhang, Shanshan, Wei, Yiying, Zhang, Liang, Zhou, Honggang, Yang, Cheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7873045/ https://www.ncbi.nlm.nih.gov/pubmed/33584285 http://dx.doi.org/10.3389/fphar.2020.607075 |
Ejemplares similares
-
Protective Effect of Remdesivir Against Pulmonary Fibrosis in Mice
por: Li, Xiaohe, et al.
Publicado: (2021) -
Byakangelicin protects against carbon tetrachloride–induced liver injury and fibrosis in mice
por: Li, Xiaohe, et al.
Publicado: (2020) -
Protective effect of Idelalisib on carbon tetrachloride‐induced liver fibrosis via microRNA‐124‐3P/phosphatidylinositol‐3‐hydroxykinase signalling pathway
por: Li, Xiaohe, et al.
Publicado: (2021) -
Antifibrotic Mechanism of Cinobufagin in Bleomycin-Induced Pulmonary Fibrosis in Mice
por: Li, Xiaohe, et al.
Publicado: (2019) -
FOXO3 regulates Smad3 and Smad7 through SPON1 circular RNA to inhibit idiopathic pulmonary fibrosis
por: Li, Hailong, et al.
Publicado: (2023)